consent. Study entry criteria of the J-ACCESS study were age ≥20 years and undergoing stress and rest myocardial perfusion SPECT because of known or suspected stable CAD. From the J-ACCESS database, we selected patients with confirmed CAD, including stable angina pectoris (AP) and prior MI, as the study population of this subanalysis protocol. The diagnosis of AP or MI was based on the final diagnosis described on the medical records in each hospital. Percutaneous coronary interventions were performed in 1,614 patients, and coronary artery bypass grafting was performed in 400 patients. Residual coronary artery stenosis identified by coronary angiography was present in 1,468 patients at the time of stress/rest perfusion imaging. Patients with the onset of MI or unstable AP within 3 months, valvular heart disease, idiopathic cardiomyopathy, severe arrhythmia, heart failure of NYHA class III or IV, or severe liver or renal disease were excluded.
In this sub-study, the following patients were excluded: 223 patients (4.8%) who were incompletely followed up for unknown reasons during the 3-year study protocol (the ultimate follow-up rate was 95.2%); 375 patients who underwent coronary revascularization within the first 60 days after the stress/rest gated SPECT studies; and 1,831 patients for whom the diagnosis of CAD was suspected, but not established, before the stress perfusion SPECT study. As a result, data from 2,200 patients with confirmed CAD, including AP and prior MI, were analyzed.
Study Design and Patient Follow-up
The J-ACCESS study design has been previously published. 2 The patients underwent stress and rest myocardial perfusion SPECT using 99m Tc-tetrofosmin and quantitative gated SPECT with an ECG-gated approach, then regularly followed up at a participating hospital for 3 years. Endpoints of this study were defined as major cardiac events: cardiac death, nonfatal MI, symptomatic heart failure requiring admission therapy, and unstable AP. When a patient had multiple cardiac events, only the first event was used as the endpoint of follow-up.
Perfusion/Function Assessment of Gated SPECT Study
Stress and rest SPECT studies were performed using a 1-day protocol (98.8%) or 2-day protocol (1.2%) with an initial dose of 305±81 MBq 99m Tc-tetrofosmin and a second dose of 709±132 MBq. [1] [2] [3] [4] [5] Depending on the patient's condition, the appropriate stress mode was selected: 68.8% underwent exercise, 28.5% had pharmacological stress tests (14.7% received dipyridamole, and 13.8% received adenosine triphosphate), and 2.7% had a dobutamine infusion. The SPECT images were divided into 20 standard segments on 3 short-axis and 1 vertical long-axis slice and the tracer uptake of each segment was visually scored as: 0, normal; 1, mildly reduced; 2, moderately reduced; 3, severely reduced; and 4, absent. 14 The summed stress score (SSS) and the summed rest score (SRS) were based on each stress and rest study. The summed difference score (SDS) was defined as the difference between SSS and SRS. Visual assessment was standardized to minimize institutional bias and interobserver errors using sample data before the start of the study as follows: the scores from a sample population of 81 patients were compared among all participating hospitals and the Image Evaluation Committee of 8 nuclear cardiology specialists. Gated SPECT data were obtained by 16 (32%), 12 (9%), 10 (3%), and 8 (56%) ECG gating frames between the RR interval and used for calculating the left ventricular ejection fraction (LVEF), end-diastolic volume (LVEDV), LVEDV index (LVEDVI), end-systolic volume (LVESV), and LVESV index (LVESVI) at rest using QGS software (Cedars-Sinai Medical Center, Los Angeles, CA, USA) and a standard processing method. The precision of the QGS parameters or preference-based variability among institutions was excellent; standard deviation of LVEF, <3.6%; coefficient of variation of LVEDV, <9.3%. [1] [2] [3] [4] [5] 
Statistical Analysis
Continuous variables are shown as the mean ± standard deviation. The mean differences between 2 groups and the prevalence of variables were compared using an unpaired t-test and 2×2 chi-square test, respectively. Differences between scintigraphic scores were examined by Wilcoxon rank-sum testing (non-parametrically distributed values). For the identification of significant variables for predicting cardiac events, univariate and subsequent multivariate stepwise logistic regression analyses were performed using the following clinical and gated SPECT data: age, sex, cardiac risks, and perfusion and functional measures derived from the gated SPECT study. For the assessment of the incremental prognostic values of significant predictors, global chisquare values were calculated after adding in several independent predictors identified by multivariate analysis based on increases in the overall likelihood ratio. 15 A P value <0.05 was considered statistically significant. These analyses were performed using a computer software program (SAS statistical program package, SAS institute, Inc, NC, USA).
Results
Of the 2,200 patients with known CAD who were studied within a 3-year period, 167 (7.6%) had cardiac events (CE group): 12 patients died of cardiac events, 34 had a nonfatal MI, 71 had unstable AP, and 50 patients had congestive heart failure requiring admission and intensive medical therapy. These patients were compared with the remaining 2,033 patients who did not have any endpoint in this analysis (non-CE group). The CE group had significantly greater age and prevalence of typical chest pain, history of heart failure, diabetes mellitus, peripheral artery disease, and chronic renal dysfunction than the non-CE group ( Table 1) .
The patients in the CE group were treated more frequently with insulin or digitalis, but less frequently with statins, than the patients in the non-CE group ( Table 1) . The CE group had significantly greater SSS, SRS, and LV cavity size (LVEDVI and LVESVI) and a smaller LVEF than the non-CE group ( Table 2) .
Results of the univariate logistic regression analysis are summarized in Tables 3 and 4 . The subsequent multivariate logistic regression analysis ( Table 5 ) revealed that among the significant predictors identified by the univariate analysis, peripheral artery disease, diabetes mellitus, no use of statins, typical chest pain, pharmacological stress test, heart rate at rest, LVESVI at rest, and SDS were independent significant predictors of primary cardiac events, with the odds ratios ranging from 1.025 to 2.291 (P=0.0309-0.0008). Secondary analysis was performed using cardiac death or symptomatic heart failure requiring admission therapy. Univariate and multivariate logistic regression analyses using cardiac death ( Table 6 ) revealed that renal Table 1 . Abbreviations see in Tables 2,3 . Abbreviations see in Tables 1-3 . Tables 2,3. failure, diabetes mellitus, LVESVI at rest, and SDS were independent significant predictors of cardiac death, with the odds ratios ranging from 1.030 to 3.929 (P=0.0416 to <0.0001). Univariate and multivariate logistic regression analyses using symptomatic heart failure requiring admission therapy ( 
Discussion
This subanalysis of the J-ACCESS database revealed the independent significant prognostic value of peripheral artery disease, diabetes mellitus, no use of statins, typical chest pain, selection of pharmacological stress test, and heart rate at rest, all of which can be easily assessed in clinical practice, in patients with known CAD. Notably, stress-related perfusion abnormality and LV enlargement are not only independent factors, but also incremental determinants of major cardiac events in combination with the pre-scan variables. Studies have already shown that the incidence of CAD in Japan is lower and patient prognosis better than in North America and Europe. The present study, however, clarified that the cardiac event rate (7.6%/3 years) in 2,200 patients with known CAD was 17.3-fold greater than that Abbreviations see in Tables 1-3 .
Figure.
Incremental global chi-square values for predicting major cardiac events when combined with independent predictors determined by multivariate analysis. By combining selected predictors one by one to get a greater global chi-square value, predictive values incrementally improved. The greatest chi-square value (110-112) was observed when the gated SPECT variable of LVESVI or SDS was added to the pre-scan clinical information. PAD, peripheral artery disease; DM, diabetes mellitus; CP, typical chest pain; pharmac., pharmacological stress test; HR, heart rate at rest; LVESVI, left ventricular end-systolic volume index; SDS, summed difference score.
Circulation Journal Vol.73, December 2009 (0.44%/3 years) in 1,831 patients with only suspected CAD. In addition, nearly identical clinical risks, such as peripheral artery disease, diabetes mellitus, and selection of pharmacological stress test, were identified in patients with CAD in Japan, as well as in developed countries. 16, 17 In the case of a selected patient population with a history of prior CAD, the incidence of subsequent cardiac events, even in the Japanese population, was likely to be greater than that in patients with suspected CAD, [6] [7] [8] [9] [11] [12] [13] [18] [19] [20] [21] [22] indicating the importance of secondary prevention in the practical clinical setting. Thus, pre-scan information and routine clinical assessment can risk-stratify patients with CAD and additional information on perfusion/function as assessed by stress/rest gated perfusion SPECT can improve the riskassessment accuracy, contributing to the establishment of secondary prevention care of coronary patients at greater risk.
Although univariate logistic regression analysis of clinical background ( Table 3 ) showed that heart failure and renal failure had high hazard ratios, neither of these parameters was selected as an independent predictor for cardiac events on the basis of the results of multivariate logistic regression analysis ( Table 5 ). In the present study, because the definition of the endpoint consisted of various types of cardiac events (not only cardiac death and symptomatic heart failure, but also MI and unstable AP), multivariate logistic regression analysis using all the types of cardiac events might have failed to identify the prognostic value of heart failure and renal failure. This explanation is supported by the results of secondary analysis evaluating the prognostic value of clinical parameters for cardiac death or heart failure (Tables 6,7) . Multivariate logistic regression analysis using these secondary endpoints demonstrated that heart failure and renal failure were strong independent predictors.
The present study identified LVESVI, but not LVEF, as a significant predictor of cardiac events in the multivariate regression analysis. In patients with prior MI and/or coronary bypass surgery, 23, 24 LVESV measured angiographically is reported to be a better predictor of survival than LVEF or LVEDV. Sharir et al 25, 26 showed that LVESV and LVEF determined by stress/rest gated perfusion SPECT have an incremental prognostic value over pre-scan and perfusion information in predicting cardiac death. Their studies, however, also indicated that LVEF was not independently associated with cardiac death or MI, [27] [28] [29] [30] [31] thus apparently supporting the present results.
In the previous results of the J-ACCESS study analysis involving 4,031 patients, 4 SSS was selected as a determinant of major cardiac events; however, the present subanalysis using only patients with established CAD identified SDS as an independent and powerful predictor for future cardiac events. Additionally, secondary analyses using only cardiac death or only symptomatic heart failure requiring admission therapy also demonstrated that SDS can provide significant predictive value for cardiac death or heart failure alone. A possible explanation is that the occurrence of cardiac death or heart failure in the patient population of the present subanalysis study of the J-ACCESS database was considered to be more closely associated with underlying residual ischemia compared with that in the J-ACCESS study, 4 because the patient population in the present study was limited to patients with established CAD. The SDS indicates residual ischemia, which is likely to be associated with non-fatal ischemic events, whereas SSS includes both reversible and fixed perfusion abnormalities and the latter is likely to be responsible for fatal cardiac events. Therefore, the difference between the analyses in the selected perfusion score can probably be explained by the inclusion of 67 events of unstable AP as major cardiac events in this sub-study. In a previous follow-up study of 1,988 Japanese patients, 32 although both SSS and SDS were identified as independent predictors of cardiac death, SDS was shown to be an independent predictor of MI and unstable AP. Those results and our present results indicate that SDS has predictive power in identifying patients at risk of repeat MI or AP among patients with CAD. Furthermore, the present study revealed that the addition of SDS and LVESVI assessed by ECG gated SPECT to the clinical, historical and exercise information significantly improved prediction of future cardiac events. 33 
Study Limitations
Reproducibility of the quantitative assessment of perfusion and function using QGS 3 was guaranteed in this multicenter study. However, there were several differences in the stress/ rest myocardial perfusion SPECT protocols in this multicenter study because of patient-oriented or facility-oriented selection as follows: 2 different protocols (1-day or 2-day), 2 stress modes (exercise or pharmacological), 2 acquisition models (180 degrees or 360 degrees) and various types of multidetector cameras (dual-detector or triple-detector) and collimators (high-resolution, general-purpose, or other). Because it was thought to be inappropriate for a comparison of parameters during stress in patients who underwent different modes of stress, heart rate and LVESVI during stress were excluded from the multivariate logistic regression analysis. Although the present study has provided information on a 3-year prognosis and risk-stratification of patients with CAD at risk for cardiac events, it was not designed to propose an appropriate management strategy. The diagnosis of unstable AP, especially the discernment of unstable angina from stable effort angina, depended on each physician at registered institutions; the decision of the optimal therapeutic strategy, including medical treatment, percutaneous coronary intervention or coronary bypass grafting, also depended on each physician. Because of the lack of detailed information about medications, including dosage and duration of administration of therapeutic agents, it was impossible to evaluate the prognostic value of medical therapies for cardiac events using multivariate logistic regression analysis. A further study is required to establish appropriate care and therapeutic strategies for patients with known CAD who are identified as being at a greater risk of cardiac events by the present method.
Conclusions
Assessment of perfusion and function using stress/rest gated myocardial perfusion SPECT has identified not only independent but also incremental prognostic value for the prediction of major cardiac events in Japanese patients with known CAD, in combination with clinical risks such as peripheral artery disease, diabetes mellitus, no use of statins, chest pain, pharmacological stress testing, and heart rate. Thus, information about LV cavity size and reversible perfusion score, in addition to the pre-scan clinical risks, can contribute to more precise identification of patients with CAD who are at greater risk so that a secondary prevention strategy may be established.
